• Define intended purpose, patient population, users, clinical workflow, operating environments, accessories and system boundaries. 

• Apply ISO 14971 risk management to identify hazards, sequences of events, hazardous situations, harms, risk controls and residual-risk decisions. 

• Identify the applicable general and particular standards using the product’s modality, classification, intended use, markets and current regulatory requirements. 

• Allocate measurable safety requirements across hardware, software, mechanical design, accessories, user interface and operating procedures. 

• Plan verification and validation early, linking every risk control and requirement to a method, acceptance criterion and retained result. 

• Maintain change control, configuration management, production controls, complaint handling and post-market feedback throughout the lifecycle. 

Application-specific safety and security challenges 

Free flow, siphoning or unintended bolus: A set-loading, door, clamp, actuator or control fault permits uncontrolled delivery, or a restart causes a transient delivery above the intended rate. 

Occlusion and under-infusion: A blocked line or inaccurate pressure estimate delays detection; the pump may store pressure and release a bolus after occlusion clears. 

Rate, volume or unit-entry error: Incorrect units, decimal placement, weight, concentration or programming mode produces an unintended dose. 

Alarm not detected or acted upon: Alarm priority, audibility, visibility, latency, alarm fatigue or user workflow prevents timely response. 

Drug library / configuration mismatch: A stale, incorrect or incompatible library and device configuration allows unsafe limits or incorrect concentration assumptions. 

Power, battery or software fault: Brownout, reset, memory corruption, task overrun, sensor drift or communication loss changes delivery or removes essential monitoring. 

Use error and foreseeable misuse: Confusing controls, ambiguous units, incomplete instructions or hurried setup contributes to programming or line-loading errors. 

Application architecture and operating context 

The system boundary may include the fluid path and disposable set, reservoir/syringe, pumping mechanism, motor and drive electronics, flow/pressure sensing, controller, user interface, drug library, alarms, power supply, battery, communications, service tools and external clinical workflow. Define which components are reusable, disposable, supplied by third parties, or outside the manufacturer’s control. 

A useful architecture view should show primary energy/material/data paths, control and monitoring paths, alarms, protective functions, user interactions, external interfaces, maintenance/service modes and reasonably foreseeable single faults. Document assumptions about accessories, environmental conditions and external systems; these assumptions become part of the verification scope and product information. 

Applicable standards and boundaries 

• IEC 60601-2-24: particular requirements for the basic safety and essential performance of infusion pumps and controllers; confirm the applicable edition and device scope. 

• IEC 60601-1: general medical electrical equipment basic safety and essential performance, where applicable. 

• ISO 14971: medical-device risk management across the lifecycle. 

• IEC 62304: medical-device software lifecycle processes for software forming part of the device. 

• IEC 60601-1-8: alarm systems for medical electrical equipment, where applicable. 

• IEC 62366-1: usability engineering for medical devices. 

• IEC 81001-5-1 and/or applicable cybersecurity guidance may be relevant to health software and connected devices; confirm product scope and jurisdiction. 

• ISO 13485: medical-device quality management system requirements. 

Applicability note: this is a screening list, not a declaration that every listed standard applies to every product. Confirm the current edition, amendments, national adoption, device classification, intended purpose, product-specific standard scope and target-market requirements before finalising the compliance matrix. Regulatory authorization or formal conformity assessment is distinct from engineering gap assessment. 

Application safety lifecycle 

1. Intended use and system definition: document users, patient population, clinical environment, interfaces, modes, accessories and exclusions. 
2. Hazard analysis and risk estimation: identify hazards, foreseeable sequences of events, hazardous situations and harms; document assumptions and risk acceptability criteria. 
3. Risk control and safety requirements: choose inherently safe design, protective measures and information for safety; derive measurable, traceable requirements. 
4. Architecture and implementation: allocate requirements to subsystems, identify dependencies and common-cause risks, and control software/hardware/configuration baselines. 
5. Verification and validation planning: define methods, fixtures, worst-case conditions, acceptance criteria, usability/clinical evidence needs and test independence. 
6. Integration and system validation: verify risk controls in the integrated device and validate intended use with representative users and environments. 
7. Release, production and post-market: maintain traceability, change impact, supplier controls, service instructions, complaint trending and periodic risk review. 

Hazards, failure scenarios and safety objectives 

The scenarios below are illustrative engineering examples, not a completed project risk analysis, a clinical recommendation, a regulatory determination or a quantitative risk estimate. Severity, probability, risk acceptability and required performance must be established for the specific device and intended use. 

ID	Illustrative hazardous scenario	Potential harm / consequence	Example engineering objective
H-01	Unintended high delivery rate or bolus	Potential overdose and serious patient injury	Prevent uncontrolled flow; monitor delivery and detect relevant faults; define interruption and alarm behaviour.
H-02	Delivery interruption or excessive under-infusion	Delayed or omitted therapy	Detect occlusion, empty reservoir, drive failure and power degradation within justified response times.
H-03	Incorrect programmed dose	Dose outside intended prescription	Use validated entry ranges, unit handling, confirmation and library controls based on intended use and risk analysis.
H-04	Alarm failure or excessive delay	Hazardous condition remains unrecognised	Specify alarm conditions, priorities, response times and performance under acoustic, visual and environmental conditions.
H-05	Restart or recovery causes unexpected delivery	Transient dose or therapy interruption	Define state retention, restart defaults, bolus handling and recovery verification.

 

Safety requirements, architecture and implementation 

Derive measurable requirements from the risk-management file and intended use. Specify supported modes, rate and volume ranges, accuracy under defined conditions, delivery behaviour during startup/shutdown, occlusion detection and recovery, free-flow controls, air-in-line detection if fitted, alarm conditions and priorities, battery reserve indication, configuration integrity, event logging, software update controls and safe response to sensor or actuator faults. Distinguish product-specific requirements from limits mandated by the applicable particular standard. Do not copy generic accuracy or alarm-time numbers without confirming the exact device class, standard edition and test method. 

Use bidirectional traceability from hazards to risk controls, system/subsystem requirements, implementation, verification results and residual-risk conclusions. Requirements should be unambiguous, testable, configuration-controlled and linked to their source. Where a requirement relies on an external standard, cite the exact clause and edition in the controlled compliance matrix rather than relying on a general statement in the blog. 

Verification, validation and safety evidence 

Build a traceable verification matrix from hazards and requirements. Test delivery accuracy across the declared operating envelope and relevant fluid/set combinations; startup, low-flow and transient behaviour; occlusion detection and post-occlusion bolus; free-flow prevention; empty-container and air detection where provided; alarm audibility/visibility; battery transition and depletion; EMC/environmental effects; software boundary conditions; data/configuration integrity; and recovery after power interruption. Use calibrated flow/pressure measurement, justified test uncertainty, representative disposables, fault injection, usability validation and independent review. Preserve raw data, configurations, software versions, deviations and rationale. 

A practical evidence set normally includes the risk-management plan and report, architecture and interface descriptions, requirements and traceability, software lifecycle records where applicable, verification protocols/results, usability engineering records, calibration and test-equipment details, deviations and resolutions, configuration baselines, supplier evidence, and justification for residual risks. The required package depends on device class, intended use, market and conformity-assessment route. 

Common pitfalls and how to detect them 

Pitfall	Recommended prevention / detection
Treating the pump as only a software problem	Analyse fluid mechanics, disposable sets, motor/drive, sensors, user interaction and clinical workflow as one system.
Using nominal accuracy alone	Test the declared envelope, low rates, startup/transients, back-pressure, fluid/set variations and uncertainty.
Alarm testing only in a quiet lab	Assess intended care environments, alarm priority, competing alarms and foreseeable user response.
Ignoring configuration and drug-library changes	Apply controlled release, compatibility checks, access control, verification and change-impact assessment.
Assuming power recovery is benign	Verify reset, retained settings, restart state, delivery interruption and any pressure-release transient.
Writing risk controls without evidence	Link each control to implementation, verification, residual-risk evaluation and production/service monitoring.

 

Relationship to adjacent disciplines 

Risk management (ISO 14971) provides the hazard/control framework; software lifecycle engineering addresses executable logic and configuration; usability engineering addresses programming and alarm interaction; cybersecurity protects libraries, settings, logs and updates; reliability engineering supports component and life assumptions; clinical evaluation and post-market surveillance assess performance in intended use. These activities are complementary, not interchangeable.

• IEC 60601-2-24 — Infusion pumps and controllers; verify current edition and amendments. 

• IEC 60601-1 — Medical electrical equipment: general requirements for basic safety and essential performance. 

• ISO 14971:2019 — Medical devices: application of risk management to medical devices; verify current status. 

• IEC 62304:2006+A1:2015 — Medical device software lifecycle processes; verify current status. 

• IEC 60601-1-8 — General requirements, tests and guidance for alarm systems in medical electrical equipment. 

• IEC 62366-1 — Application of usability engineering to medical devices. 

• ISO 13485 — Medical devices quality management systems; verify current edition. 

Currency note — Draft prepared 29 October 2026. Before publication or project use, recheck standards catalogue status, edition, amendments, national adoption and regulatory guidance for each target market. This article is engineering information, not clinical advice, a declaration of conformity, or a substitute for the manufacturer’s risk-management and regulatory processes. 

• Confirm technical reviewer and regulatory reviewer approval. 

• Verify standards editions, scopes, clauses and jurisdiction-specific requirements. 

• Confirm internal links resolve to live VerveTronics pages and use the agreed keyword map. 

• Create original architecture visual and check alt text for accessibility. 

• Ensure claims are evidence-based and do not imply guaranteed compliance, certification or regulatory approval. 

• Check metadata, canonical URL, title/H1 alignment, visible FAQ content, references and final proofreading.

VerveTronics can support medical-device teams with system safety architecture, ISO 14971 risk-file reviews, IEC 60601 standards applicability screening, software/hardware safety analyses, requirements traceability and verification/validation planning. A project-specific assessment should establish the intended use, pump type, delivery mechanism, accessories, target markets and applicable standards before defining test scope. 

Suggested CTA: Request a medical-device safety engineering or standards applicability review.

• Does IEC 60601-2-24 apply to every drug-delivery product? No. Applicability depends on the device type, intended purpose and standard scope. Confirm the current edition and whether a different particular standard or regulatory pathway applies. 
• Can a software alarm alone control an infusion hazard? Not automatically. The risk analysis should consider sensing, actuator behaviour, independent protective measures, alarm latency, foreseeable use and the consequences of a single fault. 
• Can VerveTronics certify an infusion pump? Engineering support can help prepare and review evidence; formal certification, conformity assessment or market authorization is performed by the applicable authorized body or regulator.